Identification solutions manufacturer Brady (NYSE: BRC) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 11.4% year on year to $382.6 million. Its non-GAAP profit of $1.22 per share was in line with analysts’ consensus estimates.
Is now the time to buy BRC? Find out in our full research report (it’s free).
Brady (BRC) Q1 CY2025 Highlights:
- Revenue: $382.6 million vs analyst estimates of $386.6 million (11.4% year-on-year growth, 1% miss)
- Adjusted EPS: $1.22 vs analyst estimates of $1.22 (in line)
- Management reiterated its full-year Adjusted EPS guidance of $4.56 at the midpoint
- Operating Margin: 17.6%, in line with the same quarter last year
- Free Cash Flow Margin: 14.5%, down from 18.8% in the same quarter last year
- Market Capitalization: $3.64 billion
StockStory’s Take
Brady’s Q1 performance was shaped by a combination of organic sales growth in its Americas and Asia regions and ongoing cost optimization initiatives. Management cited strong results from its core identification solutions and recent product launches, including advances in industrial label printing and RFID technology. CEO Russell Schaller emphasized the importance of R&D investment, referencing an 8% increase in spending, and highlighted the successful integration of the Gravitec acquisition and new product development for direct part marking. However, the company noted organic sales softness in Europe and Australia, which was partially offset by cost reductions and restructuring efforts.
Looking ahead, Brady’s management is focusing on mitigating the effects of global trade uncertainty, particularly around tariffs, while maintaining investment in new product development and acquisitions. The company is tightening its full-year adjusted EPS guidance, citing potential incremental tariffs and ongoing economic challenges in Europe and China. Schaller acknowledged that the evolving tariff environment presents risks but believes Brady’s geographically diversified manufacturing footprint provides flexibility. Management expects continued organic growth in the Americas and Asia, supported by expanded product offerings and efficiency initiatives, but remains cautious about macroeconomic volatility.
Key Insights from Management’s Remarks
Management attributed Q1’s performance to solid execution in core markets, strategic acquisitions, and ongoing cost control, while also addressing the impact of tariffs and regional economic pressures.
- Americas and Asia growth: Organic sales in the Americas and Asia increased by 5.4%, driven by demand for identification products and strong performance in high-growth markets like Southeast Asia. Management pointed to the success of their printer product lines and increased sales to multinational customers.
- European and Australian challenges: The company faced a 5.4% organic sales decline in Europe and Australia, which was attributed to weak industrial production, particularly in Germany, and ongoing macroeconomic pressures. However, operating income improved due to restructuring and cost control measures.
- Tariff exposure and mitigation: Brady encountered approximately $3 million in incremental tariff expenses during the quarter and expects ongoing volatility as trade policies evolve. The company is responding with targeted price increases, supply chain adjustments, and leveraging its global manufacturing network to reduce risk.
- New product launches: The launch of the I6100 industrial label printer and HH86 handheld RFID reader were highlighted as examples of successful R&D investments. These products are designed to meet industrial customer needs for high-speed, durable identification solutions.
- Acquisition activity: The acquisition of Funai’s microfluidic business expands Brady’s industrial inkjet capabilities and supports its direct part marking strategy. Management views the integration of this technology as a key differentiator for future growth.
Drivers of Future Performance
Brady’s outlook emphasizes continued investment in product innovation, strategic acquisitions, and operational efficiency, while navigating tariff uncertainty and uneven regional demand.
- Tariff and trade policy risks: Management expects tariffs to remain a significant headwind, with incremental costs estimated for upcoming quarters. The company is implementing price increases and exploring supply chain alternatives but acknowledges that prolonged tariff escalation could impact both margins and demand.
- Product development and acquisitions: Ongoing investments in R&D, including the integration of Gravitec and Funai’s microfluidics business, are expected to yield new products and expanded capabilities, supporting organic growth and deeper customer engagement.
- Regional performance variability: While the Americas and Asia are projected to continue growing, management remains cautious about recovery in Europe and China due to persistent macroeconomic challenges and shifting industrial demand patterns.
Catalysts in Upcoming Quarters
In the coming quarters, the StockStory team will monitor (1) the effectiveness of Brady’s tariff mitigation and price increase strategies, (2) the pace of integration and revenue contribution from recent acquisitions like Funai, and (3) signs of stabilization or growth in Europe and China. Product launch execution and cost management will also be key indicators of progress.
Brady currently trades at a forward P/E ratio of 14.2×. At this valuation, is it a buy or sell post earnings? Find out in our full research report (it’s free).
Now Could Be The Perfect Time To Invest In These Stocks
Market indices reached historic highs following Donald Trump’s presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth.
While this has caused many investors to adopt a "fearful" wait-and-see approach, we’re leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
